Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRaw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Current Assets (2016 - 2025)

Historic Current Assets for Outlook Therapeutics (OTLK) over the last 8 years, with Q4 2025 value amounting to $17.2 million.

  • Outlook Therapeutics' Current Assets rose 956.85% to $17.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $17.2 million, marking a year-over-year increase of 956.85%. This contributed to the annual value of $17.4 million for FY2025, which is N/A changed from last year.
  • As of Q4 2025, Outlook Therapeutics' Current Assets stood at $17.2 million, which was up 956.85% from $17.4 million recorded in Q3 2025.
  • In the past 5 years, Outlook Therapeutics' Current Assets ranged from a high of $21.1 million in Q2 2025 and a low of $15.7 million during Q4 2024